HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

calpain inhibitor III

potential anticataract drug
Also Known As:
CalI III; Cbz-Val-Phe-H; CbzValPheH; MDL 28170; MDL-28170; MDL28170; N-CBZ-Val-Phe-al; N-benzyloxycarbonylvalylphenylalaninal; N-benzyloxycarbonylvalylphenylalanine aldehyde; cBz-ValPheH; carbobenzoxyvalylphenylalanine aldehyde
Networked: 31 relevant articles (11 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Dhalla, Naranjan S: 2 articles (02/2013 - 03/2010)
2. Geddes, James W: 2 articles (07/2008 - 01/2003)
3. Wang, Cheng-Haung: 2 articles (01/2005 - 09/2004)
4. Hung, Kuo-Sheng: 2 articles (01/2005 - 09/2004)
5. Liu, Jong-Kang: 2 articles (01/2005 - 09/2004)
6. Chen, Yann-Jang: 2 articles (01/2005 - 09/2004)
7. Lee, Tsung-Hsing: 2 articles (01/2005 - 09/2004)
8. Abbott, Jinnette D: 1 article (01/2016)
9. Elmadhun, Nassrene Y: 1 article (01/2016)
10. Liu, Yuhong: 1 article (01/2016)

Related Diseases

1. Ischemia
2. Anoxia (Hypoxia)
3. Neurologic Manifestations (Neurological Manifestations)
4. Brain Injuries (Brain Injury)
5. Stroke (Strokes)

Related Drugs and Biologics

1. calpain inhibitors
2. Calpain
3. Calcium
4. Adenosine Triphosphatases (ATPase)
5. Doxycycline (Vibramycin)
6. N- (4- fluorophenylsulfonyl)- L- valyl- L- leucinal
7. AK 295
8. PD 150606
9. Spectrin
10. alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)

Related Therapies and Procedures

1. Intravenous Injections
2. Intravenous Infusions